ICC Co.,Ltd acquired 99.4% stake in CI Biotech Co., Ltd. from Yesco Holdings Co., Ltd. and E1 Corporation for KRW 9.9 trillion.
July 28, 2022
Share
ICC Co.,Ltd acquired 99.4% stake in CI Biotech Co., Ltd. from Yesco Holdings Co., Ltd. (KOSE:A015360) and E1 Corporation (KOSE:A017940) for KRW 9.9 trillion on July 29, 2022. Under the terms of consideration, ICC acquired 703 thousand shares and 95 thousand shares from Yesco and E! corp and paid KRW 8.7 trillion and KRW 1.1 trillion respectively.
ICC Co.,Ltd completed the acquisition of 99.4% stake in CI Biotech Co., Ltd. from Yesco Holdings Co., Ltd. (KOSE:A015360) and E1 Corporation (KOSE:A017940) on July 29, 2022.
E1 Corporation is a Korea-based company mainly engaged in the liquefied petroleum gas (LPG) business. The Company imports LPG mainly from Saudi Arabia, the United Arab Emirates, Kuwait, and other oil-producing countries in the Middle East, and distributes LPG to oil refining companies, gas stations and city gas companies in domestic market. It also exports LPG to overseas markets, including China, Japan, Singapore, Thailand, Vietnam and others. The Company operates terminals in Yeosu and Incheon. In addition, the Company engages in the real estate rental business.
E1 CORPORATION 
